Evidence that intrinsic iron but not intrinsic copper determines S-nitrosocysteine decomposition in buffer solution

Nitric Oxide - Biology and Chemistry

Volumn 7, Issue 3, 2002, Pages 194-209

  Vanin, Anatoly F ^a,b   Muller, Bernard ^b   Alencar, Jacicarlos L ^b   Lobysheva, Irina I ^a,c   Nepveu, Françoise ^c   Stoclet, Jean Claude ^b  

^a SEMENOV INSTITUTE OF CHEMICAL PHYSICS   (Russian Federation)

^b CNRS   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Dinitrosyl iron complexes; Iron; Nitric oxide; S nitrosothiols; Vasorelaxation

Indexed keywords

BATHOCUPROINE DISULFONIC ACID; BATHOPHENANTROLINE DISULFONIC ACID; CHELATING AGENT; COPPER ION; CYSTEINE; IRON; IRON COMPLEX; NORADRENALIN; S NITROSOCYSTEINE; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG; BATHOCUPROINE SULFONATE; BATHOPHENANTHROLINE DISULFONIC ACID; BUFFER; COPPER; DINITROSYL IRON COMPLEX; DRUG DERIVATIVE; LIGAND; NITROGEN OXIDE; PHENANTHROLINE DERIVATIVE; S NITROSOTHIOL; S-NITROSOCYSTEINE;

ANIMAL TISSUE; AORTA; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG SELECTIVITY; ELECTRON SPIN RESONANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STABILITY; RAT; VASODILATATION; ANIMAL; CHEMISTRY; KINETICS; MOUSE; WISTAR RAT;

ANIMALS; AORTA; BUFFERS; COPPER; CYSTEINE; ELECTRON SPIN RESONANCE SPECTROSCOPY; IRON; KINETICS; LIGANDS; MICE; NITROGEN OXIDES; PHENANTHROLINES; RATS; RATS, WISTAR; S-NITROSOTHIOLS; VASODILATION;

EID: 0036430357     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-8603(02)00108-8     Document Type: Article

References (58)

1. L.J. Ignarro, C.A. Gruetter, Requirement of thiols for activation of coronary arterial guanylate cyclase by glycerol trinitrite and sodium nitrite. Possible involvement of S-nitrosothiols, Biochim. Biophys. Acta 631 (1980) 221-231.
2. E.A. Kowaluk, H.-L. Fung, Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols, J. Pharmacol. Exp. Ther. 255 (1990) 1256-1264.
3. P.R. Mayers, R.L. Minor, R. Guerra, J.N. Bates, D.G. Harrison, Vasorelaxing properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide, Nature 345 (1990) 161-163.
4. J.S. Stamler, D.I. Simon, J.A. Osborne, O. Jaraki, T. Michel, D.J. Singel, J. Loscalzo, Nitrosylation of proteins with nitric oxide: Synthesis and characterization of biological active compounds, Proc. Natl. Acad. Sci. USA 89 (1992) 444-448.
5. W.R. Mathews, S.W. Kerr, Biological activity of S-nitrosothiols: The role of nitric oxide, J. Pharmacol. Exp. Ther. 267 (1993) 1529-1536.
6. R.C. Kukreja, E.P. Wei, H.A. Kontos, J.N. Bates, Nitric oxide and S-nitrosocysteine as endothelium-derived relaxing factor from acetylcholine in cerebral vessels in rats, Stroke 24 (1993) 2010-2015.
7. M. Feelisch, M. tePoel, R. Zamora, A. Deussen, S. Moncada, Understanding the controversy over the identity of EDRF, Nature 368 (1994) 62-65.
8. -) using L-cysteine, Biochem. Biophys. Res. Commun. 201 (1994) 54-62.
9. S.C. Askew, A.R. Butler, F.W. Flitney, G.D. Kemp, I.L. Megson, Chemical mechanisms underlying the vasodilator and platelet anti-aggregating properties of S-nitroso-N-acetyl-D,L- penicillamine and S-nitrosoglutathione, Bioorg. Med. Chem. 3 (1994) 54-62.
10. A.R. Butler, R.A. Field, I.R. Greig, F.W. Flitney, S.K. Bisland, F. Khan, J.F. Belch, An examination of some derivatives of S-nitroso-1-thiosugars as vasodilators, Nitric Oxide 1 (1997) 211-217.
11. H.H. Al-Sa'doni, I.L. Megson, S. Bisland, A.R. Butler, F.W. Flitney, Neocuproine, a selective Cu (I) chelator and the relaxation of rat vascular smooth muscle by S-nitrosothiols, Br. J. Pharmacol. 121 (1997) 1047-1050.
12. A.R. Butler, H.H. Al-Sa'doni, I.L. Megson, F.W. Flitney, Synthesis, decomposition and vasodilator action of some new S-nitrosated dipeptides, Nitric Oxide: Biol. & Chem. 2 (1998) 193-202.
13. I.P. Megson, S. Morton, I.R. Greig, F.A. Mazzei, R.A. Field, A.R. Butler, A. Caron, A. Gasco, R. Fruttero, D.J. Webb, N-substituted analogues of S-nitroso-N-acetyl-D,L- penicillamine: Chemical stability and prolonged nitric oxide mediated vasodilatation in isolated femoral arteries, Br. J. Pharmacol. 126 (1999) 639-648.
14. G. Stubauer, A. Guiffre, P. Sarti, Meshanism of S-nitrosothiol formation and degradation mediated by copper ions, J. Biol. Chem. 274 (1999) 28128-28133.
15. H.H. Al-Sa'doni, I.Y. Khan, L. Poston, I. Fisher, A. Ferro, A novel of S-nitrosothiols: Chemical synthesis and biological actions, Nitric Oxide 4 (2000) 550-560.
16. S.A. Gupta, T. Rupawalla, K.M. Mohhazab-H, M.S. Wolin, Regulation of NO-elicited pulmonary artery relaxation and guanylate cyclase activation by NADH oxidase and SOD, Am. J. Physiol. 276 (1999) H1535-H1542.
17. D.L.H. Williams, S-nitrosation and the reactions of S-nitroso compounds, Chem. Soc. Rev. 14 (1985) 171-196.
18. G.M. Rubanyi, A. Johns, D. Wilcox, F.V. Bates, D. Harrison, Evidence that a S-nitrosothiol, but not nitric oxide, may be identical with endothelium-derived relaxing factor, J. Cardiovasc. Pharmacol. 17 (Suppl. 3) (1991) S41-S45.
19. M. Feelisch, J.S. Stamler, Donors of nitrogen oxides, in: M. Feelisch, J.S. Stamler (Eds.), Methods in Nitric Oxide Research, Wiley, New York, 1996, p. 84.
20. M. Kashibo-Iwatsuki, M. Yamaguchi, M. Inoue, Role of ascorbic acid in the metabolism of S-nitrosoglutathione, FEBS Lett. 389 (1996) 149-152.
21. G. Scorza, D. Pietraforte, M. Minetti, Role of ascorbate and proteine thiols in the release of nitric oxide from S-nitroso-albumin and S-nitroso-glutathione in human plasma, Free Radicals Biol. Med. 22 (1997) 633-642.
22. A. Xu, J.A. Vita, J.F. Keaney, Ascorbic acid and glutathione modulate the biological activity of S-nitrosoglutathione, Hypertension 36 (2000) 149-152.
23. J. McAninly, D.L.H. Williams, S.C. Askew, A.R. Butler, C. Russel, Metal ions catalysis in nitrosothiol (RSNO) decomposition, J. Chem. Soc. Chem. Commun. (1993) 1758-1759.
24. M.P. Gorge, D.J. Meyer, J. Hothersall, G.H. Neild, N.N. Payne, A. Noronha-Dutra, Copper chelator-induced reduction of the biological activity of S-nitrosothiols, Br. J. Pharmacol. 114 (1995) 1038-1049.
25. D.L.H. Williams, The mechanism of nitric oxide formation from S-nitrosothiols (thionitrites), Chem. Commun. 1 (1996) 1085-1091.
26. R.J. Singh, N. Hogg, J. Joseph, B. Kalyanaraman, Mechanism of nitric oxide release from S-nitrosothiols, J. Biol. Chem. 271 (1996) 18596-18603.
27. + as the effective reagent in nitric oxide formation from S-nitrosothiols (RSNO), J. Chem. Soc. Perkin Trans. 2 (1996) 481-487.
28. A.F. Gorren, A. Schrammel, K. Schmidt, B. Mayer, Decomposition of S- nitrosoglutathione in the presence of copper and glutathione, Arch. Biochem. Biophys. 330 (1996) 219-228.
29. A.R. Butler, P. Rhodes, Chemistry, anazlysis and biological roles of S-nitrosothiols, Anal. Biochem. 249 (1997) 1-9.
30. A.P. Dicks, E. Li, A.P. Munro, H.R. Swift, D.L.H. Williams, The reaction of S- nitrosothiols with thiols at high thiol concentration, Can. J. Chem. 76 (1997) 789.
31. A.P. Dicks, P.H. Beloso, D.L.H. Williams, Decomposition of S-nitrosothiols: The effect of added thiols, J. Chem. Soc. Perkin Trans. 2 (1997) 1429-1434.
32. A.F. Vanin, I.V. Malenkova, V.A. Serezhenkov, Iron catalyzes both decomposition and synthesis of S-nitrosothiols: Optical and EPR studies, Nitric Oxide: Biol. & Chem. 1 (1997) 191-203.
33. A.F. Vanin, Dinitrosyl iron complexes and S-nitrosothiols are two possible forms for stabilization and transport of nitric oxide in biological systems, Biochemistry (Moscow) 67 (1998) 782-793.
34. B. Gaston, Nitric oxide and thiol groups, Biochim. Biophys. Acta 1411 (1999) 323-333.
35. E. Sorenson, E.H. Skiles, B. Xu, S. Aleryani, P. Kostka, Role of redox-active iron ions in the decomposition of S-nitrosocysteine in subcellular fractions of porcine aorta, Eur. J. Biochem. 267 (2000) 4593-4599.
36. M.P. Gorge, J.S. Hothersall, G.H. Neild, A.A. Noronha-Dutra, Role of copper(I)-dependent enzyme in anti-platelet action of S-nitrosoglutathione, Br. J. Pharmacol. 119 (1996) 536-538.
37. P.G. Sammes, G. Yahioglu, 1.10-Phenantroline: A versatile ligand, Chem. Soc. Rev. 23 (1994) 327-334.
38. A.F. Vanin, V.A. Serezhenkov, I.V. Malenkova, Nitric oxide initiates iron binding to neocuproine, Nitric Oxide 5 (2001) 166-175.
39. A.F. Vanin, R.A. Stukan, E.B. Manukhina, Physical properties of dinitrosyl-iron complexes with thiol-containing ligands in relation to their vasodilartor activity, Biochim. Biophys. Acta 1259 (1996) 5-12.
40. 2 reaction, Chem. Res. Toxicol. 7 (1994) 5129-5525.
41. P.H. Beloso, D.L.H. Williams, Reversibility of S-nitrosothiol formation, Chem. Commun. 1 (1997) 89-91.
42. Y.P. Vedernikov, P.I. Mordvintcev, I.V. Malenkova, A.F. Vanin, Similarity between the vasorelaxing activity of dinitrosyl iron cysteine complexes and endothelium-derived relaxing factor, Eur. J. Pharmacol. 211 (1992) 313-317.
43. A.F. Vanin, Role of iron and cysteine in formation and decomposition of S- nitrosocysteine and S-nitrosoglutathione, Biochemistry (Moscow) 60 (1996) 441-447.
44. F.-W. Sheu, W. Zhu, P.C.W. Fung, Direct observation of trapping and release of nitric oxide by glutathione and cysteine with electron paramagnetic resonance spectroscopy, Biophys. J. 78 (2000) 1216-1226.
45. I.I. Lobysheva, V.A. Serezhenkov, A.F. Vanin, Interaction of peroxynitrire and hydrogen peroxyde with dinitrosyl thiol-containing iron complexes, Biochemistry (Moscow) 64 (1999) 153-158.
46. P.M. Bush, J.P. Whitehead, C.C. Pink, E.C. Gramm, J.L. Eglin, S.P. Watton, L.E. Pence, Electronic and structural variation among copper(II) complexes with substituted phenatrolines, Inorg. Chem. 40 (2001) 1871-1877.
47. C.C. McDonald, W.D. Phillips, H.F. Mower, An electron spin resonance study of some complexes of iron, nitric oxide and anionic ligands, J. Am. Chem. Soc. 87 (1965).
48. A.F. Vanin, Identification of divalent iron complexes with cysteine in biological systems by EPR method, Biokhimiya (Rus.) 32 (1967) 228-323.
49. A. Zai, M.A. Rudd, A.W. Scriber, J. Loscalzo, Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide, J. Clin. Invest. 103 (1999) 393-399.
50. Y.L. Geng, A.-S. Petersson, A. Wennmalm, G. Hannson, Cytokine-induced expresssion of nitric oxide synthesis results in nitrosylation of heme and non-heme iron proteins in vascular smooth muscle cells, Exp. Cell. Res. 214 (1994) 418-429.
51. E.L. Yee, Effect of nitric oxide on heme metabolism in pulmonary artery endothelial cells, Am. J. Physiol. 271 (1996) L512-L518.
52. J.-C. Stoclet, E. Troncy, B. Muller, C. Brua, A.L. Kleschyov, Molecular mechanisms underlying the role of nitric oxide in the cardiovascular system, Exp. Opin. Invest. Drugs 7 (1998) 1769-1779.
53. B. Muller, A.L. Kleschyov, S. Malblanc, J.-C. Stoclet, Nitric oxide-related cyclic GMP-independent relaxing effect on N-acetylcysteine in lipopolysaccharide-treated rat aorta, Br. J. Pharmacol. 123 (1998) 1221-1229.
54. J.-C. Stoclet, B. Muller, K. Gyorgy, R. Andriansitohaina, A.L. Kleschyov, The inducible NO-synthase in vascular and cardiac tissue, Eur. J. Pharmacol. 375 (1999) 139-155.
55. A.M. Komarov, I.T. Mak, W.B. Weglicki, The origin of dinitrosyl-iron complex in endothelial cells, Ann. N-Y. Acad. Sci. 899 (2000) 407-410.
56. Y.-M. Kim, H.-T. Cheng, R.L. Simmons, T. Billiar, Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis and caspase inhibition, J. Biol. Chem. 275 (2000) 10954-10979.
57. V.M. Bolotina, S. Najibi, J.J. Palacino, P.J. Pagano, R.A. Cohen, Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle, Nature 368 (1994) 850-853.
58. F. Plane, J.Y. Wiley, J.Y. Jeremy, R.A. Cohen, C.J. Garland, Evidence that different mechanisms underlie smooth muscle relaxation to nitric oxide and nitric oxide donors in the rabbit isolated carotid artery, Br. J. Pharmacol. 123 (1998) 1351-1358.